Basics |
Korro Bio, Inc.
|
IPO Date: |
October 4, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$150.06M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.92 | 4.36%
|
Avg Daily Range (30 D): |
$1.03 | 6.46%
|
Avg Daily Range (90 D): |
$1.15 | 5.06%
|
Institutional Daily Volume |
Avg Daily Volume: |
.3M |
Avg Daily Volume (30 D): |
.07M |
Avg Daily Volume (90 D): |
.07M |
Trade Size |
Avg Trade Size (Sh.): |
137 |
Avg Trade Size (Sh.) (30 D): |
49 |
Avg Trade Size (Sh.) (90 D): |
47 |
Institutional Trades |
Total Inst.Trades: |
264 |
Avg Inst. Trade: |
$1.93M |
Avg Inst. Trade (30 D): |
$.57M |
Avg Inst. Trade (90 D): |
$.96M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.78M |
Avg Closing Trade (30 D): |
$1.69M |
Avg Closing Trade (90 D): |
$1.21M |
Avg Closing Volume: |
143.32K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-9.44
|
$-2.49
|
$-2.26
|
Diluted EPS
|
$-9.44
|
$-2.49
|
$-2.26
|
Revenue
|
$ 4.82M
|
$ 2.55M
|
$ 2.27M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -87.41M
|
$ -23.39M
|
$ -21.2M
|
Operating Income / Loss
|
$ -95.48M
|
$ -25.02M
|
$ -23.04M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -78.21M
|
$ 8.5M
|
$ -9.33M
|
PE Ratio
|
|
|
|
|